Evidence map›Paper›PMID 29479558›Full record

ArticleTobacco regulatory science2018

Plasma Menthol Glucuronide as a Biomarker of Acute Menthol Inhalation.

Peter Jatlow, Gerald Valentine, Ralitza Gueorguieva, Haleh Nadim, Ran Wu, Stephanie S O'Malley, Mehmet Sofuoglu

Open access · diamondAbstract read
In one paragraph

Article in Tobacco regulatory science, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Modulation of "Protective" Nicotine Perception and Use Profile by Flavorants: Preliminary Findings in E-cigarettes.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2020
    Article
  8. Effects of Menthol Flavor Cigarettes or Total Urinary Menthol on Biomarkers of Nicotine and Carcinogenic Exposure and Behavioral Measures.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Peter JatlowProfessor Emeritus in Laboratory Medicine and in Psychiatry, Yale School of Medicine, New Haven, CT.
Gerald ValentineClinician in Psychiatry, Department of Psychiatry, Yale School of Medicine, New Haven, CT.
Ralitza GueorguievaSenior Research Scientist in Biostatistics, Director of Biostatistics in Psychiatry, Yale School of Public Health, New Haven, CT.
Haleh NadimResearch Associate, Department of Laboratory Medicine, Yale School of Medicine, New Haven, CT.
Ran WuStatistician, Department of Psychiatry, Yale School of Medicine, New Haven, CT.
Stephanie S O'MalleyProfessor, Department of Psychiatry, Yale School of Medicine, New Haven, CT.
Mehmet SofuogluProfessor, Department of Psychiatry, VA CT Healthcare System and Yale School of Medicine, New Haven, CT.
Yale University · USCancer Research And Biostatistics · USVA Connecticut Healthcare System · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Yale Tobacco Center of Regulatory ScienceP50DA036151 · NIDA · YALE UNIVERSITY · PI KRISHNAN-SARIN, SUCHITRA, O'MALLEY, STEPHANIE S · 2013 to 2017
$20.6M
NCATS NIH HHS UL1 TR001863NIDA NIH HHS P50 DA036151
6 · The paper itself

Abstract

objectivesMenthol is often added to cigarettes and e-cigarette solutions for its cooling and anti-irritant effects, and may contribute to development of nicotine dependence, particularly in vulnerable populations such as adolescents, and among African Americans. Menthol is rapidly metabolized to menthol glucuronide (MG) with little or no unconjugated menthol measurable in venous blood. Human challenge studies of the effects of inhaled menthol, and of its interactions with nicotine, would benefit from a quantitative measure of acute menthol exposure. Our objective was to determine whether plasma MG concentrations might be a suitable quantitative biomarker of acute menthol exposure following its inhalation.

methodsWe performed a secondary analysis of plasma MG concentrations obtained during a study of the effects of inhaled menthol on behavioral responses to intravenous nicotine. MG concentrations were followed over time in venous plasma from 48 participants following inhalation of aerosols from e-cigarettes employing solutions containing either of 2 menthol concentrations or placebo.

resultsWhereas plasma MG concentrations were variable, they showed a dose-dependent increase following menthol inhalation.

conclusionsMeasurement of plasma MG may be useful to assess inter-individual differences in acute menthol exposure in human challenge studies involving menthol inhalation.

Indexed as

e-cigarettesENDSmentholmenthol glucuronide

Identifiers

PMID29479558
PMCPMC5822727
OpenAlexW2773073166

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.